Trofosfamide

CAS No. 22089-22-1

Trofosfamide( —— )

Catalog No. M26852 CAS No. 22089-22-1

Trofosfamide is a derivative of oxazaphosphorine with antineoplastic potency.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 34 In Stock
10MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Trofosfamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Trofosfamide is a derivative of oxazaphosphorine with antineoplastic potency.
  • Description
    Trofosfamide is a derivative of oxazaphosphorine with antineoplastic potency.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22089-22-1
  • Formula Weight
    323.58
  • Molecular Formula
    C9H18Cl3N2O2P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (309.04 mM)
  • SMILES
    ClCCN(CCCl)P1(=O)OCCCN1CCCl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oftedal L, et al. Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid. Sci Rep. 2020;10(1):22098. Published 2020 Dec 16.
molnova catalog
related products
  • (Rac)-Dencichin

    (Rac)-Dencichin (2-Amino-3-(carboxyformamido)propanoic acid) is the racemate of Dencichin.

  • Diphenyl Blue

    Diphenyl Blue (Direct Blue 14) is used as a dye for a group of azo dye.

  • Oleclumab

    Oleclumab (MEDI9447) is a human anti-CD73 monoclonal antibody with anticancer activity that inhibits the extracellular enzyme CD73 nucleic acid exonuclease activity, inhibits the adenosine pathway, and can be used for the study of metastatic desmoplasia-resistant prostate cancer.